In Asian countries favoring loco-regional treatment such as surgical resection or ablation, very early-stage hepatocellular carcinoma (HCC) should be the main target for surveillance. Even though ultrasound (US) has been accepted as a primary imaging modality for HCC surveillance, its performance in detecting very early-stage HCCs is insufficient. Moreover, in more than 20% of patients at high risk for HCC, visualization of the liver on US may be limited owing to the advanced distortion and heterogeneity of the liver parenchyma. Recently revised HCC clinical guidelines allow the use of alternative surveillance tools including computed tomography or magnetic resonance imaging in patients with inadequate US exams. This paper summarizes the findings of recent studies using imaging modalities other than US as surveillance tools for HCC as well as strengths and limitations of these modalities.
Citations
Citations to this article as recorded by
A systematic review of comparisons of AI and radiologists in the diagnosis of HCC in multiphase CT: implications for practice Jarrod Younger, Emily Morris, Nicholas Arnold, Chanchala Athulathmudali, Janani Pinidiyapathirage, William MacAskill Japanese Journal of Radiology.2026; 44(1): 97. CrossRef
Long‐Term Outcome of Chronic Hepatitis B—Histological Score and Viral Genotype Are Important Predictors of Hepatocellular Carcinoma Anders Eilard, Johan Ringlander, Maria E. Andersson, Staffan Nilsson, Gunnar Norkrans, Magnus Lindh Journal of Viral Hepatitis.2025;[Epub] CrossRef
Recent advances and issues in imaging modalities for hepatocellular carcinoma surveillance Dong Ho Lee Journal of Liver Cancer.2025; 25(1): 31. CrossRef
Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Ki, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim Annals of Surgical Treatment and Research.2025; 109(3): 123. CrossRef
Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Kim, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim Journal of Liver Cancer.2025; 25(2): 140. CrossRef
Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography Dong Wook Kim, Won Chang, So Yeon Kim, Young-Suk Lim, Jonggi Choi, Jungheum Cho, Jin-Wook Kim, Jai Young Cho, Sun Kyung Jeon, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Kyung-Suk Suh, Kwang-Woong Lee, Dong Ho Lee Clinical and Molecular Hepatology.2025; 31(4): 1285. CrossRef
Advanced Imaging of Hepatocellular Carcinoma: A Review of Current and Novel Techniques Trinh Nguyen, Jaijo Vennatt, Lincoln Downs, Venkateswar Surabhi, Nir Stanietzky Journal of Gastrointestinal Cancer.2024; 55(4): 1469. CrossRef
Imaging features of hepatobiliary MRI and the risk of hepatocellular carcinoma development Jong-In Chang, Dong Hyun Sinn, Woo Kyoung Jeong, Jeong Ah Hwang, Ho Young Won, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung-Woon Paik Scandinavian Journal of Gastroenterology.2022; 57(12): 1470. CrossRef